Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Benchmarking whole exome sequencing in the German network for personalized medicine

8 Sept 2024

Abstract excerpt

INTRODUCTION: Whole Exome Sequencing (WES) has emerged as an efficient tool in clinical cancer diagnostics to broaden the scope from panel-based diagnostics to screening of all genes and enabling robust determination of complex biomarkers in a single analysis. METHODS: To assess concordance, six formalin-fixed paraffin-embedded (FFPE) tissue specimens and four commercial reference standards were analyzed by WES...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39293347
DOI: 10.1016/j.ejca.2024.114306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Benchmarking whole exome sequencing in the German network for personalized medicinePMID 39293347Read ↗

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsSemantic proximity Read ↗

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testingSemantic proximity Read ↗

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.Semantic proximity Read ↗

Whole-exome sequencing as a diagnostic tool: current challenges and future opportunitiesSemantic proximity Read ↗

Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.Semantic proximity Read ↗

Clinical validation of Whole Genome Sequencing for cancer diagnosticsSemantic proximity Read ↗

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.Semantic proximity Read ↗

Whole Genome and Exome Sequencing Reference Datasets from A Multi-center and Cross-platform Benchmark StudySemantic proximity Read ↗

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Semantic proximity Read ↗

Findings from Precision Oncology in the Clinic: Rare, Novel Variants are a Significant Contributor to Scaling Molecular DiagnosticsSemantic proximity Read ↗

Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application.Semantic proximity Read ↗

New insights into the performance of human whole-exome capture platforms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.